Buscar
Congreso SOLACI

Artículos del autor

Dr. Omar Tupayachi

Member of the Editorial Board of solaci.org
Antiplatelet

ESC 2024 | QUADRO Trial: Efficacy and Safety of the First Quadruple Therapy Single Pill in Resistant Hypertension Patients

Researchers conducted an international, randomized, parallel-group study with a superiority design over a 16-week period. The doses...
Dr. Omar Tupayachi -
Other

ESC 2024 | STOP-or-NOT Trial: Optimal Management of Renin-Angiotensin System Inhibition Before Non-Cardiac Surgery

Researchers conducted a multicenter, randomized study to assess the continuation of renin-angiotensin system inhibition (RASI) before major...
Dr. Omar Tupayachi -
Acute coronary syndromes

ESC 2024 | AßYSS: Discontinuation of Beta-Blocker Treatment After One Year in Uncomplicated MI

Researchers presented a non-inferiority study conducted at 49 centers in France, with a randomized cohort of stable post-acute...
Dr. Omar Tupayachi -
Structural heart disease

SAFE-Vein: Percutaneous Closure Devices in Complex Venous Accesses

For certain structural interventions and procedures in the field of interventional electrophysiology, complex venous access (CVA) using...
Dr. Omar Tupayachi -
Chronic Coronary Syndromes

Tomographic Data from ISCHEMIA According to AI and Cardiovascular Risk

Coronary computed tomography angiography (CCTA) is an increasingly popular alternative to invasive diagnosis. This technique allows for...
Dr. Omar Tupayachi -
Acute coronary syndromes

Colchicine in Coronary Plaque Stabilization: Results According to OCT

Cardiovascular inflammation has been globally recognized and accepted in recent years as a key factor in the...
Dr. Omar Tupayachi -
Peripheral vascular disease

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac...
Dr. Omar Tupayachi -
Left Atrial Apendix Closure

Left Atrial Appendage Occlusion and Early Bleeding

Percutaneous left atrial appendage occlusion (LAAO) is presented as an alternative to chronic oral anticoagulation in patients...
Dr. Omar Tupayachi -

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

Dr. Andrés Rodríguez - 0
In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

Dr. Andrés Rodríguez - 0
The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

TCT 2024 | Distal Radial vs Transradial Approach in STEMI Patients

Dr. Andrés Rodríguez - 0
The transradial approach (TRA) has been recommended for patients with ST-elevation myocardial infarction (STEMI) for reduced bleeding complications and mortality. However, evidence in support...

Noticias Institucionales

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad